Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LDK378 in Patients With Non-small Cell Lung Cancer Harboring ROS1 Rearrangement
NCT01964157Phase 2Completed
- Sponsor
- Yonsei University
- Start
- Sep 2013
- Primary completion
- Jan 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ceritinib in non-small cell lung cancer (NSCLC), sponsored by Yonsei University. Started Sep 2013; status: completed.
02
Drugs
ceritinib
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT01964157.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01964157.